[go: up one dir, main page]

CN1850065A - Oral use of conjugated linoleic acid and its derivatives for muscle building and skin beautification - Google Patents

Oral use of conjugated linoleic acid and its derivatives for muscle building and skin beautification Download PDF

Info

Publication number
CN1850065A
CN1850065A CN 200510034419 CN200510034419A CN1850065A CN 1850065 A CN1850065 A CN 1850065A CN 200510034419 CN200510034419 CN 200510034419 CN 200510034419 A CN200510034419 A CN 200510034419A CN 1850065 A CN1850065 A CN 1850065A
Authority
CN
China
Prior art keywords
cla
linoleic acid
skin
conjugated linoleic
muscle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 200510034419
Other languages
Chinese (zh)
Inventor
杨得坡
曾晓晖
何国瑞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhongshan Unicare Natural Medicine Co ltd
Original Assignee
Zhongshan Unicare Natural Medicine Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhongshan Unicare Natural Medicine Co ltd filed Critical Zhongshan Unicare Natural Medicine Co ltd
Priority to CN 200510034419 priority Critical patent/CN1850065A/en
Publication of CN1850065A publication Critical patent/CN1850065A/en
Pending legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention relates to the use of Conjugated Linoleic Acid (CLA) and its derivatives for oral administration for building up body, reducing weight, nourishing skin and beautifying skin, and also relates to the use of Conjugated Linoleic Acid (CLA) and its derivatives for animal health care. The invention relates to the application of Conjugated Linoleic Acid (CLA) and derivatives thereof in preparing oral preparations for strengthening body, protecting skin, nourishing and beautifying; the preparation comprises tablet, soft capsule, granule, capsule and pill. The invention has the advantages that: conjugated Linoleic Acid (CLA) and its derivatives can enter skin and muscle tissue by oral administration, promote metabolism, and remove or replace melanin to achieve skin whitening and caring effects; or increasing the content of myoglycogen, myosin, actin and myoglobin, promoting the generation of muscle cells, and achieving the effect of increasing the muscle volume and the muscle fiber strength.

Description

口服共轭亚油酸及其衍生物用于增肌健体与皮肤美容的用途Oral use of conjugated linoleic acid and its derivatives for muscle building and skin beautification

【技术领域】【Technical field】

本发明涉及共轭亚油酸(CLA)及其衍生物口服用于增肌、健体、减肥和护肤美容的用途,本发明还涉及共轭亚油酸(CLA)及其衍生物用于动物保健的用途。本发明还涉及有关制剂的制备方法和其他组合物。The present invention relates to the use of conjugated linoleic acid (CLA) and its derivatives for oral use in muscle building, body building, weight loss and skin care and beauty. The present invention also relates to the use of conjugated linoleic acid (CLA) and its derivatives in animals Health care use. The present invention also relates to methods for the preparation of related formulations and other compositions.

【背景技术】【Background technique】

现代社会,由于科学技术的高速发展,机械化电气化、自动化、深入到人类社会的各个领域,使得人们的体力劳动消耗量大幅度降低,包括家庭主妇们每天必不可少的家务劳动,也都被现代化的设备所取代。人们日常的体力消耗量已经下降至半个世纪之前的十分之一还不到。In modern society, due to the rapid development of science and technology, mechanization, electrification, automation, and penetration into various fields of human society, people's physical labor consumption has been greatly reduced, including housewives' daily essential housework, which has also been modernized. equipment replaced. People's daily physical exertion has dropped to less than one-tenth of what it was half a century ago.

另一方面,随着饮食文化的飞速发展,各种美味食品花样繁多层出不穷,多数人已经不再为能否填饱肚子而发愁,品尝各种美味食品已经成为时尚,单位聚餐、朋友聚会、节假日改善伙食谈生意请客吃饭,探病送营养食品,各种因素促使着人们在不知不觉中吃进过量的食物。On the other hand, with the rapid development of food culture, various delicious foods emerge in endlessly. Most people no longer worry about whether they can fill their stomachs. Tasting various delicious foods has become fashionable. Improve meals, talk about business, treat guests to dinner, and send nutritious food to sick people. Various factors urge people to eat too much food without knowing it.

现代人由于体力消耗减少,又过分追加营养,造成人体能量代谢失衡,导致高粘血症、高脂血症、糖尿病、高血压、冠心病等一系列现代病。肥胖病便是这些现代病之一。二十一世纪的健康杀手——肥胖病愈来愈引起国际医学界的关注,所以有专家提出:肥胖症已和吸烟、艾滋病一起成为威胁人类健康的三大严重问题。Due to the reduction of physical exertion and excessive supplementation of nutrients in modern people, the energy metabolism of the human body is unbalanced, leading to a series of modern diseases such as hyperviscosity, hyperlipidemia, diabetes, hypertension, and coronary heart disease. Obesity is one of these modern diseases. The health killer in the 21st century—obesity has attracted more and more attention from the international medical community, so some experts pointed out that obesity has become three serious problems threatening human health together with smoking and AIDS.

近年来,减肥成为一种时尚。但是如何才能健康有效地减肥,同时又能健美?In recent years, losing weight has become a fashion. But how can you lose weight in a healthy and effective way while still looking toned?

有专家提出了一种新的减肥理念-----营养减肥!即好的减肥方法,优秀的减肥产品,才是健康减肥的唯一途径。选择好的减肥食品,通过均衡的营养,合理的膳食,达到瘦身健美的效果。营养调控减肥,一种新的理念,抛弃沉重的赘肉,重塑自我。Some experts put forward a new concept of weight loss ----- nutritional weight loss! That is, good weight loss methods and excellent weight loss products are the only way to lose weight healthily. Choose good weight loss food, through balanced nutrition, reasonable diet, to achieve the effect of weight loss and fitness. Nutritional regulation and weight loss, a new concept, discard heavy fat and reshape yourself.

“不腹泻、不节食、不乏力”是国际通行的健康减肥三原则。有些减肥药中掺有刺激代谢的药物(有的还是违禁药物,如安非那酮等),通过排泄消耗人体水分和未来得及消化吸收的食物,达到减轻人体重量的目的。其危害是引起虚脱、腹痛、恶心、呕吐、电解质紊乱、营养不良等后果,虽然也能暂时减重,但减掉的不只是脂肪,还有水、矿物质和蛋白质等重要物质,而且停药后便会反弹增肥。节食减肥的实质就是过度减少能量摄入。其危害和抑制食欲一样,能引起失眠、头晕、恶心、呕吐、营养不良、免疫功能下降。可导致神经性厌食症,重者危及生命。腹泻和节食都会造成乏力。"No diarrhea, no dieting, no fatigue" are the three internationally accepted principles of healthy weight loss. Some weight-loss drugs are mixed with drugs that stimulate metabolism (some are illegal drugs, such as bupropion, etc.), and the purpose of reducing body weight is achieved by excreting and consuming body water and food that will not be digested and absorbed in the future. The harm is that it can cause collapse, abdominal pain, nausea, vomiting, electrolyte imbalance, malnutrition and other consequences. Although it can also temporarily lose weight, it loses not only fat, but also important substances such as water, minerals and protein, and the drug is discontinued. Then it will rebound and gain weight. The essence of dieting to lose weight is to excessively reduce energy intake. Its harm is the same as that of suppressing appetite. It can cause insomnia, dizziness, nausea, vomiting, malnutrition, and decreased immune function. Can lead to anorexia nervosa, severe cases are life-threatening. Both diarrhea and dieting can cause fatigue.

因此需要寻求一种物质,这种物质能通过改善营养分配,达到减肥的目的,并且不产生失眠、头晕、恶心、呕吐、营养不良、免疫功能下降等副作用。同时,改善营养分配的协同效果是增加肌肉组织,增强肌体整体素质,实现健美的体态。Therefore, it is necessary to seek a substance that can achieve the goal of weight loss by improving nutrition distribution, and does not produce side effects such as insomnia, dizziness, nausea, vomiting, malnutrition, and decreased immune function. At the same time, the synergistic effect of improving nutrient distribution is to increase muscle tissue, enhance the overall quality of the body, and achieve a healthy body.

国外研究证明,体内共轭亚油酸可能通过减少脂肪沉积和增加脂肪细胞中脂肪的分解来降低身体脂肪。国外有学者指出,共轭亚油酸可能以两种不同的方式抑制脂肪细胞的形成,包括抑制其增殖和抑制其分化。Park等人(Park Y.et al.Effect of conjugated linoleic acid on bodycomposition in mice[J].Lipids,1997,32:853-858)的实验结果证实了,共轭亚油酸降低老鼠身体脂肪的生理学上的机理包括抑制脂肪细胞中脂肪的储存以及加快骨骼肌中的β氧化和增加骨骼肌重量。West等人发现(West D.B.Conjugated linoleic acid rapidly reduces body fat content in mice withoutaffecting energy intake[J].Am.J.Physiol.1999;276:R1172-R1179.),与不含共轭亚油酸的对照组相比,用含共轭亚油酸混合物的食物喂养的老鼠其身体脂肪的百分比下降了70%,同时身体中水分、蛋白质和灰分的百分比显著增加。Foreign studies have proved that conjugated linoleic acid in the body may reduce body fat by reducing fat deposition and increasing fat breakdown in fat cells. Foreign scholars have pointed out that CLA may inhibit the formation of adipocytes in two different ways, including inhibiting their proliferation and inhibiting their differentiation. The experimental results of Park et al. (Park Y. et al. Effect of conjugated linoleic acid on bodycomposition in mice [J]. Lipids, 1997, 32: 853-858) confirmed that conjugated linoleic acid reduces the physiology of mouse body fat The above mechanisms include inhibition of fat storage in adipocytes and acceleration of β-oxidation in skeletal muscle and increase in skeletal muscle mass. West et al found (West D.B.Conjugated linoleic acid rapidly reduces body fat content in mice withoutaffecting energy intake[J].Am.J.Physiol.1999; 276:R1172-R1179.), compared with the control without conjugated linoleic acid Rats fed a diet containing the CLA mixture had a 70 percent decrease in body fat percentage, while their body water, protein and ash percentages increased significantly compared to the control group.

Ha等人的研究发现CLA具有抗癌作用(Ha Y,et al.Inhibition of benz[a]pyrene-inducedmouse forestomach neoplasis by conjugated dienoic derivatives of linoleic acid[J].CancerRes.,1990,50:1097-1101.),并据此推断CLA为抗氧化剂,之后的CLA抗氧化性能测试表明,CLA具有强于VE的抗氧化性能。Ha et al's research found that CLA has anticancer effect (Ha Y, et al.Inhibition of benz[a]pyrene-inducedmouse forestomach neoplasis by conjugated dienoic derivatives of linoleic acid[J].CancerRes., 1990,50:1097-1101 .), and accordingly infer that CLA is an antioxidant, and the subsequent CLA antioxidant performance test shows that CLA has stronger antioxidant performance than VE.

有人把CLA同小鼠皮肤癌角质细胞共同培养,结果表明:CLA抑制TPA可以诱导产生的PEG2和AA。CLA通过调节细胞膜的磷脂成分,保护细胞膜的磷脂酶不被激活,减少花生四烯酸释放产生PEG2(Liu KL,Belury MA.Conjugated linoleic acid reduces arachidonic acidcontent and PGE2 synthesis in murine keratinocytes.Cancer letters 1998;127:15-22)。另有研究发现9z,lle-CLA能特异性结合真皮内过氧化物增殖体激活受体-α(PPAR-α),促进角质细胞的分化,抑制皮肤肿瘤的癌变(Thuillier P,et al.Activators of peroxisomeproliferator-activated receptor-αpartially inhibit mouse skin tumor promotion.Molecular Carcinogenesis 2000;29:134-142.。通过测定真皮中成纤维细胞合成的I型原胶原和与其相关联的Derorin蛋白的方式来研究CLA。将CLA和EGCG的不同组合与人体真皮中成纤维细胞共同培养,结果表明,CLA和EGCG单独使用均能提高I型原胶原的含量,并且两者的联合使用具有协同作用。而I型原胶原和与其相关联的Derorin蛋白含量的提高可以平滑皱纹,修复光损伤性皮肤,表现出抗衰老的作用。CLA具有清除自由基和抗脂质过氧化作用(WO0182861 Treatment of skin damage using conjugated linoleic acid and ascorbyl fattyacid esters),促进皮肤胶原细胞生长,维持细胞的增殖周期,防止细胞朝衰老、分化方向发展,从而发挥抗衰老,抗炎作用。Someone co-cultured CLA with mouse skin cancer keratinocytes, and the results showed that: CLA can inhibit the production of PEG2 and AA that can be induced by TPA. CLA regulates the phospholipid composition of the cell membrane, protects the phospholipase of the cell membrane from being activated, and reduces the release of arachidonic acid to produce PEG2 (Liu KL, Belury MA. Conjugated linoleic acid reduces arachidonic acid content and PGE 2 synthesis in murine keratinocytes. Cancer letters 1998; 127:15-22). Another study found that 9z, lle-CLA can specifically bind to peroxisome proliferator-activated receptor-α (PPAR-α) in the dermis, promote the differentiation of keratinocytes, and inhibit the carcinogenesis of skin tumors (Thuillier P, et al. Activators of peroxisome proliferator-activated receptor-α partially inhibit mouse skin tumor promotion. Molecular Carcinogenesis 2000;29:134-142. CLA was studied by measuring the synthesis of type I procollagen and its associated Derorin protein by fibroblasts in the dermis. Different combinations of CLA and EGCG were co-cultured with fibroblasts in human dermis. The results showed that both CLA and EGCG alone could increase the content of type I procollagen, and the combined use of the two had a synergistic effect. While type I procollagen The improvement of the Derorin protein content associated with it can smooth wrinkles, repair photodamaged skin, and show anti-aging effects. CLA has scavenging free radicals and anti-lipid peroxidation (WO0182861 Treatment of skin damage using conjugated linoleic acid and ascorbyl fatty acid esters), promote the growth of skin collagen cells, maintain the proliferation cycle of cells, prevent cells from developing in the direction of aging and differentiation, thereby exerting anti-aging and anti-inflammatory effects.

在US6551602;US2004043963;US6403064;WO0182861专利中公开了CLA在局部用组合物和皮肤美容保健中的用途,如抗皱纹,增强皮肤弹性和厚度,修复光损伤性皮肤,美白作用,以及保湿,营养,抗炎和抗过敏等。在US6300374中公开了共轭亚油酸的锌盐可治疗多种皮肤病,如湿疹、牛皮、皮炎等。这些研究或已公开的专利表明CLA外用可以营养或护理裸露皮肤,我们假设口服的CLA也可以达到皮肤部位发挥同样药理作用。US6551602; US2004043963; US6403064; WO0182861 patents disclose the use of CLA in topical compositions and skin beauty care, such as anti-wrinkle, enhancing skin elasticity and thickness, repairing photodamaged skin, whitening effect, and moisturizing, nutrition, Anti-inflammatory and anti-allergic etc. It is disclosed in US6300374 that the zinc salt of conjugated linoleic acid can treat various skin diseases, such as eczema, psoriasis, dermatitis and the like. These studies or published patents suggest that topical CLA can nourish or care for bare skin, and we hypothesize that oral CLA can also reach the skin site to exert the same pharmacological effects.

基于上述考虑,本申请人通过实验意外惊人地发现口服共轭亚油酸(CLA)及其衍生物能改善营养分配、减肥增肌、增强免疫能力,同时还具有皮肤营养与美容的作用。Based on the above considerations, the applicant unexpectedly discovered through experiments that oral administration of conjugated linoleic acid (CLA) and its derivatives can improve nutrition distribution, lose weight and increase muscle, enhance immunity, and also have skin nutrition and beauty effects.

【发明内容】【Content of invention】

本发明的目的是将共轭亚油酸(CLA)及其衍生物口服用于增肌、健体、减肥、皮肤营养与护肤美容的用途,尤其用于增肌健体(健美)的用途。本发明还涉及共轭亚油酸(CLA)及其衍生物用于动物保健的用途。本发明还涉及有关制剂的制备方法和其他组合物。The object of the present invention is to orally administer conjugated linoleic acid (CLA) and its derivatives for muscle building, fitness, weight loss, skin nutrition and skin care, especially for muscle building (bodybuilding). The invention also relates to the use of conjugated linoleic acid (CLA) and its derivatives for animal health. The present invention also relates to methods for the preparation of related formulations and other compositions.

实际上,本发明涉及共轭亚油酸(CLA)及其衍生物在制备用于增肌健体和护肤营养、美容用途的口服制剂的应用;In fact, the present invention relates to the application of conjugated linoleic acid (CLA) and its derivatives in the preparation of oral preparations for muscle building, skin care, nutrition and cosmetic purposes;

如上所述的应用,共轭亚油酸(CLA)及其衍生物口服进入皮肤与肌肉组织,促进其新陈代谢,清除或置换黑色素,达到美白嫩肤之效;或增加肌糖原、肌球蛋白、肌动蛋白和肌红蛋白的含量,促进肌肉细胞生成,达到增加肌肉体积和肌纤维强度的功效;As mentioned above, conjugated linoleic acid (CLA) and its derivatives orally enter the skin and muscle tissue to promote their metabolism, remove or replace melanin, and achieve the effect of whitening and skin rejuvenation; or increase muscle glycogen, myosin , the content of actin and myoglobin, promote the generation of muscle cells, and achieve the effect of increasing muscle volume and muscle fiber strength;

如上所述的制剂,其制剂包括片剂、软胶囊、冲剂、颗粒剂、胶囊剂和丸剂;As above-mentioned preparation, its preparation comprises tablet, soft capsule, electuary, granule, capsule and pill;

如上所述的制剂,制剂含有任选的一种或多种常用的具抗氧化生理活性物质;The above-mentioned preparation, the preparation contains optional one or more commonly used antioxidant physiologically active substances;

如上所述的CLA及其衍生物,其中CLA包含一种或多种9,11-10,12-和11,13-十八碳二烯酸的顺式和反式形式异构体;CLA衍生物为CLA的乙酯、甘油三酯,钙盐、锌盐以及其他可能的衍生物或盐;CLA and derivatives thereof as described above, wherein CLA comprises one or more cis and trans form isomers of 9,11-10,12- and 11,13-octadecadienoic acid; CLA derived The substance is ethyl ester, triglyceride, calcium salt, zinc salt and other possible derivatives or salts of CLA;

如上所述的CLA及其衍生物,其特征在于共轭亚油酸(CLA)及其衍生物的用量为0.01-20%(W/W);The above CLA and its derivatives, characterized in that the amount of conjugated linoleic acid (CLA) and its derivatives is 0.01-20% (W/W);

如上所述的制剂,常用的具抗氧化生理活性物质为维生素E或TBHQ或茶多酚或硒(Se);As mentioned above, the commonly used antioxidant physiologically active substances are vitamin E or TBHQ or tea polyphenols or selenium (Se);

如上所述的制剂,常用的具抗氧化生理活性物质,除了保护CLA及其衍生物发挥正常生理功能外,还起着协同清除体内自由基的作用,特别针对肌肉增加,肌体活动增强后产生更多的自由基状况,达到清洁肌体内环境的功效。As mentioned above, the commonly used antioxidant physiologically active substances, in addition to protecting CLA and its derivatives to exert normal physiological functions, also play a role in synergistic scavenging of free radicals in the body, especially for muscle growth and more active substances after body activity is enhanced. There are many free radicals, so as to achieve the effect of cleaning the internal environment of the human body.

本发明采用了细胞实验和动物实验来研究共轭亚油酸(CLA)及其衍生物减脂增肌,健美体态和营养皮肤的作用。The invention adopts cell experiments and animal experiments to study the effects of conjugated linoleic acid (CLA) and its derivatives on reducing fat and increasing muscle, building body and nourishing skin.

细胞实验采用小鼠3T3-L1脂肪前体细胞。3T3-L1细胞株是小鼠胚胎来源、具有纤维母细胞形态的前脂肪细胞,是目前国际上公认的研究成脂过程的细胞株。在分化诱导刺激下,3T3-L1前体脂肪细胞分化为成熟的脂肪细胞。本研究利用脂肪前体细胞体外培养实验,脂肪前体细胞在加入分化诱导剂的培养液中培养分化。实验设2个试验组,对照组和CLA组。对照组培养液中不加入其他物质培养;CLA组则在培养液中加入CLA(浓度呈梯度变化),培养至第八天时进行形态学观察,与对照组来比较。The cell experiments used mouse 3T3-L1 preadipocytes. The 3T3-L1 cell line is a preadipocyte derived from mouse embryos and has a fibroblast morphology. It is currently an internationally recognized cell line for studying the process of adipogenicity. Under differentiation-inducing stimuli, 3T3-L1 preadipocytes differentiate into mature adipocytes. In this study, the in vitro culture experiment of adipocytes was used, and adipocytes were cultured and differentiated in the culture medium added with differentiation inducers. The experiment consisted of two test groups, the control group and the CLA group. The culture medium of the control group was cultured without adding other substances; the culture medium of the CLA group was cultured with CLA (concentration changed in a gradient), and the morphology was observed on the eighth day, and compared with the control group.

结果:比较对照组,CLA组的细胞明显多呈纤维状,散见细小油滴,表明对3T3-L1脂肪前体细胞的增殖以及向脂肪细胞的分化有一定抑制作用,提示共轭亚油酸(CLA)具有潜在的减肥、降脂作用。Results: Compared with the control group, the cells in the CLA group were obviously fibrous, and small oil droplets were scattered, indicating that it had a certain inhibitory effect on the proliferation of 3T3-L1 adipose precursor cells and the differentiation into adipocytes, suggesting that conjugated linoleic acid (CLA) has potential weight loss and lipid-lowering effects.

动物实验主要研究了共轭亚油酸(CLA)及其衍生物改善肌体肌肉组成和促进营养物质再分配,实现结实肌肉和肌体肌肉分布均匀的减肥健美的作用,同时还研究了实验动物的皮肤状态。CLA组试验动物明显优于对照组:皮肤光泽度好,较少出现因皮肤疾病所致的不正常斑点或肤色。共轭亚油酸(CLA)及其衍生物这些优点,是目前市场上热销的减肥产品所无法比拟的。Animal experiments mainly studied the effects of conjugated linoleic acid (CLA) and its derivatives on improving body muscle composition and promoting the redistribution of nutrients to achieve weight loss and bodybuilding with firm muscles and uniform distribution of body muscles. At the same time, the skin of experimental animals was also studied. state. The test animals in the CLA group were significantly better than the control group: the skin gloss was better, and there were fewer abnormal spots or skin colors caused by skin diseases. These advantages of conjugated linoleic acid (CLA) and its derivatives are unmatched by the hot-selling slimming products on the market.

实验设2个试验组:空白对照组与共轭亚油酸钙(共轭亚油酸钙为共轭亚油酸钙盐的存在形式,简称:CLA-Ca)组,每个试验组均设2个重复组,每个重复组设5头猪,共20头试验猪(2♀,3♂/重复)。试验猪在试验前均测定体重,确保每个重复组间试验猪体重、体型差异检验不显著。预试期5天,正式试验期64天。There were 2 test groups in the experiment: blank control group and conjugated linoleic acid calcium (conjugated linoleic acid calcium is the form of conjugated linoleic acid calcium salt, referred to as: CLA-Ca) group, each test group was set 2 There were 2 repetition groups, 5 pigs in each repetition group, a total of 20 test pigs (2♀, 3♂/replication). The body weight of the test pigs was measured before the test to ensure that the test pigs' body weight and body shape were not significantly different among each repeated group. The pre-test period is 5 days, and the formal test period is 64 days.

CLA-Ca粉按6.7‰的剂量(折合纯CLA-Ca 5.0‰)直接添加到对应试验组猪的粉状饲料中,搅拌均匀,每天连续饲喂。The dose of CLA-Ca powder was 6.7‰ (equivalent to pure CLA-Ca 5.0‰) directly into the powdered feed of pigs in the corresponding test group, stirred evenly, and fed continuously every day.

生产性能指标测定:实验阶段始末记录的猪个体称重,记录每重复组的采食量、计算平均日增重、料肉比、日采食量。Determination of production performance indicators: Weigh the individual pigs recorded at the beginning and end of the experimental stage, record the feed intake of each repeated group, and calculate the average daily gain, feed-to-meat ratio, and daily feed intake.

活体测膘分级采用B超仪分别于实验阶段的始末在动物试验现场进行活体测膘分级,检测项目包括B超测量背膘厚、眼肌面积,估算胴体瘦肉率。In vivo fat measurement and grading adopt B-ultrasound instrument to carry out in-vivo fat measurement and grading at the animal test site at the beginning and end of the experimental stage. The testing items include B-ultrasound measurement of backfat thickness, eye muscle area, and estimation of carcass lean meat percentage.

试验结束后,空白组、CLA-Ca组每栏挑选体型中等猪各2头(♀,♂各1头),共8头,空腹24h后屠宰,按GB8467-87《瘦肉型猪性能测定技术规程》方法进行,测定眼肌面积、背膘厚、肌间脂肪、计算胴体瘦肉率。分割左侧胴体瘦肉、脂肪、皮、骨称重;测定屠宰后45分钟在第13~14肋间测背最长肌的pH值,进行肉色和大理石纹级别评定。实验结果见表1-3:结果详见表1-3:After the test, 2 medium-sized pigs (1 each for ♀ and 1 ♂) were selected from each column of the blank group and the CLA-Ca group, a total of 8 pigs were slaughtered after 24 hours of fasting. "Procedures" method, measuring eye muscle area, backfat thickness, intermuscular fat, and calculating carcass lean meat percentage. Divide the lean meat, fat, skin, and bone of the left carcass and weigh them; measure the pH value of the longissimus dorsi muscle at the 13th to 14th intercostal space 45 minutes after slaughter, and evaluate the meat color and marbling grade. The experimental results are shown in Table 1-3: the results are detailed in Table 1-3:

                    表1 CLA钙对肥育猪增重效果及饲料转化效率的影响   初重(kg)   末重(kg)   日增重(g)   饲料转化效率   日采食量(kg/d·头)   对照组试验组   59.25059.750   102.20098.550   681.75±10.10624.60±16.83   3.91±0.053.82±0.28   2.712.42 Table 1 Effect of CLA calcium on weight gain and feed conversion efficiency of finishing pigs Initial weight(kg) Final weight(kg) Daily weight gain (g) feed conversion efficiency Daily feed intake (kg/d head) control group test group 59.25059.750 102.20098.550 681.75±10.10624.60±16.83 3.91±0.053.82±0.28 2.712.42

                                  表2 CLA钙对屠体性状的影响   测试指标   对照组   试验组   测试指标   对照组   试验组   宰前体重(kg)胴体重(kg)屠宰率(%)后腿比例(%)胴体瘦肉率(%)   103.25±4.5576.04±3.1573.67±1.9829.17±1.6055.41±5.57   100.5±1.4773.32±3.0372.96±2.7830.90±1.9859.84±2.31   头重(kg)皮脂重(kg)骨重(kg)后腿重(kg)瘦肉重(kg)   6.85±0.9510.04±2.226.52±0.2211.16±0.6220.54±1.93   6.19±0.488.90±1.565.63±0.8611.1±0.3521.66±0.80 Table 2 Effect of CLA calcium on carcass traits Test indicators control group test group Test indicators control group test group Pre-mortem body weight (kg) carcass weight (kg) slaughter percentage (%) hind leg ratio (%) carcass lean meat percentage (%) 103.25±4.5576.04±3.1573.67±1.9829.17±1.6055.41±5.57 100.5±1.4773.32±3.0372.96±2.7830.90±1.9859.84±2.31 Head Weight (kg) Sebum Weight (kg) Bone Weight (kg) Hind Leg Weight (kg) Lean Weight (kg) 6.85±0.9510.04±2.226.52±0.2211.16±0.6220.54±1.93 6.19±0.488.90±1.565.63±0.8611.1±0.3521.66±0.80

                                     表3 CLA钙对胴体性状的影响   测试指标   对照组   试验组   测试指标   对照组   试验组   肩部最厚处膘厚(mm)6-7肋膘厚(mm)最后肋膘厚(mm)荐部前沿膘厚(mm)平均膘厚(mm)   41.18±7.2228.53±6.6815.58±6.0413.4±7.5624.68±6.77   33.2±8.8722.1±4.8315.4±5.1415.95±4.5121.68±5.07   B超膘厚(mm)胴体眼肌面积(cm2)B超眼肌面积(cm2)估计瘦肉率(%)估计瘦日增重(g/天.头)   21.35±9.6647.26±7.2637.84±1.7151.55±1.37205.55±11.72   15.05±4.3650.49±4.7440.08±2.4655.01±1.17212.33±4.82 Table 3 Effect of CLA calcium on carcass traits Test indicators control group test group Test indicators control group test group Fat thickness at the thickest part of the shoulder (mm) 6-7 rib fat thickness (mm) last rib fat thickness (mm) fat thickness at the front of the shoulder (mm) average fat thickness (mm) 41.18±7.2228.53±6.6815.58±6.0413.4±7.5624.68±6.77 33.2±8.8722.1±4.8315.4±5.1415.95±4.5121.68±5.07 B-ultrasound fat thickness (mm) carcass eye muscle area (cm 2 ) B-ultrasound eye muscle area (cm 2 ) estimated lean meat percentage (%) estimated lean daily gain (g/day.head) 21.35±9.6647.26±7.2637.84±1.7151.55±1.37205.55±11.72 15.05±4.3650.49±4.7440.08±2.4655.01±1.17212.33±4.82

以上实验表明:The above experiments show that:

(1)皮肤状态和肉品质评价:试验组皮肤白净红润,被毛整洁发亮,较少出现因皮肤疾病造成的红疹、斑块等异常皮肤现象,显示出CLA对皮肤状态的改进功能;肉品质评价方面,试验组的肉色评分比对照组提高了。(1) Evaluation of skin condition and meat quality: the skin of the test group was fair and ruddy, the coat was neat and shiny, and there were less abnormal skin phenomena such as rashes and plaques caused by skin diseases, showing the improvement function of CLA on skin condition; In terms of meat quality evaluation, the meat color score of the experimental group was higher than that of the control group.

(2)身体整体体型和肌肉状态评价:体型上,试验组育肥猪身型长,背平直,腹部肌肉结实收缩,臀部肌肉浑圆结实且分布均匀,活动状态强。屠宰分割后可见,试验组育肥猪肌纤维的增粗和纵裂增殖使肌肉的体积增大、重量增加,其表现为肌肉形态得到了改变,故身体整体体型得到良性发展。(2) Evaluation of overall body shape and muscle state: In terms of body shape, the fattening pigs in the test group were long in body, straight in back, firm and contracted in abdominal muscles, round and firm in hip muscles and evenly distributed, and in a strong state of activity. After slaughtering and dividing, it can be seen that the thickening of muscle fibers and the proliferation of longitudinal fissures in the fattening pigs in the test group increased the volume and weight of the muscles, which manifested as changes in the shape of the muscles, so the overall shape of the body was benignly developed.

(3)对增重效果及饲料转化效率的影响:与对照组比较,试验组的日增重,平均日采食量和料重比都降低了。(3) Effects on weight gain and feed conversion efficiency: Compared with the control group, the daily weight gain, average daily feed intake and feed-to-weight ratio of the experimental group were all reduced.

(4)屠宰率、胴体性状:试验组的后腿比例、胴体瘦肉率、胴体眼肌面积和B超眼肌面积提高了,平均膘厚、B超膘厚和皮脂相对重比对照组下降了。试验组的瘦肉率显著高于对照组。(4) Slaughter rate and carcass traits: the proportion of hind legs, carcass lean meat percentage, carcass eye muscle area and B-ultrasound eye muscle area in the experimental group increased, and the average fat thickness, B-ultrasonic fat thickness and relative sebum weight decreased compared with the control group up. The lean meat percentage of the test group was significantly higher than that of the control group.

人呼吸氧气进入体内,有一部份转化为活性自由基,会导致细胞衰老,皱纹增多,记忆力减退,削弱免疫系统。因此,摄入抗氧化剂能有效清除活性自由基,延缓机体和皮肤衰老。When people breathe oxygen into the body, some of it is transformed into active free radicals, which will cause cell aging, increase wrinkles, memory loss, and weaken the immune system. Therefore, the intake of antioxidants can effectively scavenge active free radicals and delay the aging of the body and skin.

本发明采用了连苯三酚自氧化法研究共轭亚油酸(CLA)及其衍生物的抗氧化作用。The invention adopts a pyrogallol autoxidation method to study the antioxidant effect of conjugated linoleic acid (CLA) and its derivatives.

将连苯三酚用稀盐酸配成6mmol/L的溶液。将0.02%的样品加入到4.1mL的pH8.2缓冲液中,混合均匀。取0.1mL的连苯三酚液加到上述混合液中,在紫外分光光度仪上采用时间程序在320nm处连续测量300s,连苯三酚自氧化速率用每分钟其自氧化产物在波长320nm处的吸光度增加量 表示。样品对连苯三酚自氧化速率的百分抑制率由式(1-1)计算。Make a 6mmol/L solution of pyrogallol with dilute hydrochloric acid. Add 0.02% of the sample to 4.1 mL of pH 8.2 buffer and mix well. Take 0.1mL of pyrogallol solution and add it to the above mixed solution, and use the time program on the ultraviolet spectrophotometer to measure continuously at 320nm for 300s. The increase in absorbance express. The percentage inhibition rate of the sample pyrogallol autoxidation rate was calculated by formula (1-1).

结果见表4。The results are shown in Table 4.

Figure A20051003441900082
Figure A20051003441900082

式中, 为对照组连苯三酚自氧化速率; 为加入样品时的连苯三酚自氧化速率。实验结果见表4:In the formula, is the autoxidation rate of pyrogallol in the control group; is the autoxidation rate of pyrogallol when adding the sample. The experimental results are shown in Table 4:

表4 CLA及其乙酯对超氧阴离子的抑制率   样品     抑制率(%)   CLACLA乙酯维生素E     24.3221.637.21 Table 4 Inhibition rate of superoxide anion by CLA and its ethyl ester sample Inhibition rate(%) CLACLA Ethyl Ester Tocopherol 24.3221.637.21

上述结果表明在连苯三酚自氧化体系试验中,相同浓度下本发明的CLA和CLA乙酯具有比维生素E更强的清除超氧阴离子的作用,是一种有效的抗氧化剂。The above results show that in the pyrogallol autoxidation system test, CLA and CLA ethyl ester of the present invention have a stronger superoxide anion scavenging effect than vitamin E at the same concentration, and are an effective antioxidant.

本发明所述的共轭亚油酸(CLA)及其衍生物口服用于减肥增肌和护肤美容的用途,将30例肥胖病人(自愿者)随机分为两组,一组分天服用4.5gCLA,另一组只服不含任何成分的安慰剂。试食3个月后,测定发现,受试者在食用CLA后,腰围、腹围、臀围显著减小,尤以腰围、腹围更明显,人体皮下脂肪厚度也明显减少。统计结果表明,安慰组体重下降率为0%;共轭亚油酸组体重下降率为100%,平均体重下降了12.5%,同时体脂比例显著减少,肌肉比例明显增加,说明受试产品具有减肥与增加肌肉的作用。Conjugated linoleic acid (CLA) and derivatives thereof described in the present invention are used orally for weight loss, muscle gain and skin care and cosmetic purposes. 30 obese patients (volunteers) were randomly divided into two groups, and one group took 4.5 gCLA, and the other group received only a placebo containing nothing. After 3 months of food testing, it was found that after eating CLA, the subjects' waist circumference, abdominal circumference, and hip circumference decreased significantly, especially the waist circumference and abdominal circumference, and the thickness of subcutaneous fat in the human body also decreased significantly. The statistical results show that the weight loss rate of the placebo group is 0%; the body weight loss rate of the CLA group is 100%, with an average weight loss of 12.5%. Lose weight and increase muscle.

本发明与现有产品相比具有如下的优点:共轭亚油酸(CLA)及其衍生物口服进入皮肤与肌肉组织,促进其新陈代谢,清除或置换黑色素,达到美白嫩肤之效;或增加肌糖原、肌球蛋白、肌动蛋白和肌红蛋白的含量,促进肌肉细胞生成,达到增加肌肉体积和肌纤维强度的功效。Compared with the existing products, the present invention has the following advantages: Conjugated linoleic acid (CLA) and its derivatives are taken orally into the skin and muscle tissue to promote their metabolism, remove or replace melanin, and achieve the effect of whitening and skin rejuvenation; The content of muscle glycogen, myosin, actin and myoglobin can promote the production of muscle cells and achieve the effect of increasing muscle volume and muscle fiber strength.

【具体实施方式】【Detailed ways】

下面将描述本发明的几个具体实施方式,但本发明的内容完全不局限于此。Several specific embodiments of the present invention will be described below, but the content of the present invention is not limited thereto.

实施例1:CLA功能调和油Example 1: CLA functional blend oil

(1)取5gCLA与芝麻油、橄榄油或葵花子油混合均匀,配成100g调和油,分装后得成品。食用方式:直接作为食用油加入沙拉或其他生、熟食品的调味佐品中。(1) Mix 5g of CLA with sesame oil, olive oil or sunflower oil evenly to make 100g of blended oil, and obtain the finished product after packaging. Ways of eating: Add directly as cooking oil to salads or other seasonings for raw and cooked foods.

实施例2:含共轭亚油酸及其衍生物的功能型食品Example 2: Functional food containing conjugated linoleic acid and its derivatives

(1)CLA巧克力:取1gCLA与可可浆、可可粉、可可脂、奶粉、食用油脂、砂糖、乳化剂及香料按一定比例混合均匀得100g,用旋转磨辊使其微粒化,并用精磨机精磨后,再用旋转磨辊加工成粉末细片状,过60目的筛,最后用成型机压榨机成型。(1) CLA chocolate: Mix 1g of CLA with cocoa pulp, cocoa powder, cocoa butter, milk powder, edible oil, sugar, emulsifier and spices in a certain proportion to obtain 100g, use a rotating grinding roller to make it micronized, and use a fine grinder After fine grinding, it is processed into fine powder flakes with a rotating grinding roller, passed through a 60-mesh sieve, and finally shaped by a molding machine press.

(2)CLA-Ca糖果:将白砂糖放入铝锅中,加水少许,煎熬至挑起即成丝状而不粘时,将温度降至40℃,加入5g CLA钙粉,配成100g,熄火。将糖倒在表面涂过食用油的搪瓷盘中,待稍冷,用刀将糖割成小块即可。(2) CLA-Ca candy: Put white granulated sugar in an aluminum pot, add a little water, and cook until it becomes silky and not sticky, then lower the temperature to 40°C, add 5g of CLA calcium powder, and make 100g. turn off the flame. Pour the sugar into an enamel plate coated with edible oil, wait for it to cool slightly, and cut the sugar into small pieces with a knife.

(3)制备含CLA的西点糖粉:取10gCLA与西点糖粉混合得100g,搅拌,研碎,过60目筛,分装,即得成品。(3) Preparation of pastry sugar powder containing CLA: Mix 10 g of CLA and pastry sugar powder to obtain 100 g, stir, grind, pass through a 60-mesh sieve, and pack separately to obtain the finished product.

实施例3:含共轭亚油酸及其衍生物的营养补品Example 3: Nutritional supplements containing conjugated linoleic acid and its derivatives

(1)含CLA-Ca的合剂:取3gCLA-Ca粉与蔗糖、肌苷、儿茶酚、苯甲酸钠按一定比例混合,用100mL蒸馏水溶解,充分搅拌,使之完全溶解。分装于易拉罐中,即得。服用方法:加入牛奶或其他运动型饮料和食品中食用。(1) Mixture containing CLA-Ca: Mix 3g of CLA-Ca powder with sucrose, inosine, catechol, and sodium benzoate in a certain proportion, dissolve in 100mL of distilled water, stir well to make it completely dissolved. Packed in cans, that is. Directions for use: Add to milk or other sports drinks and food.

(2)制备含CLA的泡腾片:取5gCLA和枸橼酸、富马酸、碳酸氢钠按一定比例混合均匀,用乙醇制成软材,过60目筛,制粒,所得颗粒于60℃干燥,整粒,加入低取代羟丙基纤维素,硬脂酸镁充分混合均匀得100g,以12mm浅凹冲压片,即得。服用方法:加入牛奶或其他运动型饮料和食品中食用。(2) Preparation of effervescent tablets containing CLA: get 5g of CLA and mix them uniformly with citric acid, fumaric acid, and sodium bicarbonate in a certain proportion, make a soft material with ethanol, pass through a 60-mesh sieve, and granulate. Dry at ℃, granulate, add low-substituted hydroxypropyl cellulose and magnesium stearate, mix thoroughly to obtain 100g, punch out tablets with 12mm dimples, and obtain. Directions for use: Add to milk or other sports drinks and food.

实施例4:含共轭亚油酸及其衍生物的保健品和药品原料Example 4: Health care products and pharmaceutical raw materials containing conjugated linoleic acid and its derivatives

(1)制备含CLA钙盐的硬胶囊剂:取5gCLA钙盐,与维生素E、蔗糖、淀粉按一定比例混合配成100g,粉碎后,过100目筛,装入硬胶囊,即得。(1) Preparation of hard capsules containing CLA calcium salt: get 5g of CLA calcium salt, mix it with vitamin E, sucrose, and starch in a certain proportion to make 100g, after crushing, pass through a 100-mesh sieve, and pack into hard capsules.

(2)制备含CLA的软胶囊剂:将明胶、甘油、蒸馏水按40∶12∶48的比例混合配成胶液,将胶液和CLA分别通过滴丸机双孔,按不同速度滴出,在冷却的液体石蜡中进行凝固,三者的用量比例为1.12∶0.9∶0.86。所得的胶丸于20℃左右干燥,即得。服用方法:口服,温开水或牛奶送服。(2) Preparation of CLA-containing soft capsules: gelatin, glycerin, and distilled water are mixed in a ratio of 40:12:48 to form a glue solution, and the glue solution and CLA are passed through the double holes of the dropping pill machine and dripped out at different speeds. Solidify in the cooled liquid paraffin, the dosage ratio of the three is 1.12:0.9:0.86. The obtained capsules are dried at about 20°C to obtain. Dosage: Take orally, take with warm water or milk.

(3)共轭亚油酸微囊剂:取3gCLA与乙基纤维素,淀粉,滑石粉,硬脂酸甘油,维生素E等按一定比例溶于100ml乙醇中,混合均匀,于喷雾干燥机中喷雾干燥,即得。使用方法:作为药物和食品生产原料用。(3) Conjugated linoleic acid microcapsules: Dissolve 3g of CLA, ethyl cellulose, starch, talcum powder, glycerin stearate, vitamin E, etc. in 100ml of ethanol in a certain proportion, mix well, and place in a spray dryer Spray drying, that is. Usage: used as raw material for medicine and food production.

(4)制备含CLA的口腔速溶片:取5gCLA与多糖、明胶、多肽,滑石粉,乙醇、着色剂等按一定比例配成混悬液,定量分装于一定模具中,冷冻成固态,再减压升温,通过升华作用除去水分,得到高孔隙率的固体制剂100g。服用方法:不需水送服,在口内遇到唾液迅速溶解。(4) Prepare the oral instant tablet containing CLA: get 5g CLA and polysaccharide, gelatin, polypeptide, talcum powder, ethanol, coloring agent etc. are made into suspension in certain proportion, quantitatively subpackage in certain mould, freeze into solid state, then The temperature was raised under reduced pressure, and water was removed by sublimation to obtain 100 g of a high-porosity solid preparation. How to take: Take it without water, it dissolves quickly when it encounters saliva in the mouth.

(5)制备含CLA的口含片:将乳糖、糖粉、17%淀粉浆按一定比例混合均匀,过60目筛,湿颗粒放干燥箱内干燥(60℃-80℃),得空白颗粒。取5gCLA与空白颗粒混合得100g,用压片机压制成片,即得。服用方法:舌下含服。(5) Preparation of buccal tablets containing CLA: mix lactose, sugar powder, and 17% starch slurry evenly in a certain proportion, pass through a 60-mesh sieve, and dry the wet granules in a drying oven (60°C-80°C) to obtain blank granules . Take 5g of CLA and mix it with blank granules to obtain 100g, and press it into tablets with a tablet machine. How to take: Take it sublingually.

(6)制备含CLA的微囊:将乙基纤维素(EC)溶于丙酮中,再加入2gCLA和0.7g滑石粉,搅拌,所得混悬液加入到含有司盘的液体石蜡中,将体系温度逐渐升至35℃,保温搅拌,升温至57℃,搅拌,减压抽滤,所得固体物用正己烷洗涤3次,抽干,干燥,制得100g微囊。(6) Preparation of CLA-containing microcapsules: dissolve ethyl cellulose (EC) in acetone, add 2 g of CLA and 0.7 g of talc, stir, and add the resulting suspension to liquid paraffin containing Span, and the system The temperature was gradually raised to 35°C, kept stirring, then raised to 57°C, stirred, filtered under reduced pressure, the obtained solid was washed 3 times with n-hexane, drained and dried to obtain 100 g of microcapsules.

(7)制备含CLA乙酯的营养液:取2gCLA乙酯与蜂蜜、蔗糖酯、维生素E、硒、蛋白糖、脱氢乙酸钠按一定比例混合,加水至100ml,搅拌均匀,均质,然后装瓶、封口、灭菌后,得成品。(7) Preparation of nutrient solution containing CLA ethyl ester: mix 2g of CLA ethyl ester with honey, sucrose ester, vitamin E, selenium, protein sugar, and sodium dehydroacetate in a certain proportion, add water to 100ml, stir evenly, and then After bottling, sealing, and sterilization, the finished product is obtained.

实施例5:含有共轭亚油酸及其衍生物动物食粮和饲料Example 5: Animal Food and Feed Containing Conjugated Linoleic Acid and Its Derivatives

(1)直接添加入动物食粮和饲料:取5gCLA钙粉与95g狗粮或猪饲料混合,搅拌均匀,即得。(1) Add directly to animal food and feed: Mix 5g of CLA calcium powder with 95g of dog food or pig feed, and stir evenly.

(2)生产宠物食粮的原料添加剂:取0.05gCLA与鸡胸肉、山梨糖醇、红曲米素、维生素E、山梨酸钾、糖精钠、亚硝酸钠按一定比例混合配成100g,将混合物控水去油、冷冻切片、烘干、包装,即得。(2) Raw material additives for the production of pet food: take 0.05g of CLA and mix it with chicken breast meat, sorbitol, red yeast rice, vitamin E, potassium sorbate, sodium saccharin, and sodium nitrite in a certain proportion to form 100g, and control the mixture Degreasing with water, freezing and slicing, drying, packing, and it is ready.

(3)生产动物饲料的原料添加剂:将玉米、豆粕、麸皮,剔除杂质,90℃烘18h,按10∶3∶2的比例进行粗混合,用球蘑机粉碎并通过80目筛,取筛粉95g与5gCLA钙粉混合均匀,分装于洗净棕色瓶中,充氮气,封口后,用1.5兆拉德的剂量进行同位素钴60照射,以便长期保存。(3) Raw material additives for the production of animal feed: remove impurities from corn, soybean meal, and bran, bake at 90°C for 18 hours, roughly mix them in a ratio of 10:3:2, crush them with a ball mushroom machine and pass through an 80-mesh sieve, and take Mix 95g of sieved powder with 5g of CLA calcium powder evenly, pack them into clean brown bottles, fill them with nitrogen gas, seal them, and irradiate them with the isotope cobalt 60 at a dose of 1.5 Mrad for long-term storage.

Claims (8)

1, conjugated linoleic acid (CLA) and derivant thereof are used for the application of the oral formulations of increasing muscule and skin-care nutrient, beautifying use in preparation.
2, application according to claim 1, oral skin and the muscular tissue of entering of conjugated linoleic acid (CLA) and derivant thereof promotes its metabolism, removes or displacement melanin, reaches the effect of whitening and softening skin; Or the content of increase muscle glycogen, myosin, actin and Myoglobin, promote muscle cell to generate, reach the effect that increases muscle volume and muscle fiber intensity.
3, preparation according to claim 1, its preparation comprises tablet, soft capsule, electuary, granule, capsule and pill.
4, according to claim 2 or 3 described preparations, preparation contains one or more optional tool antioxidation biological active substanceies commonly used.
5, CLA according to claim 1 and derivant thereof, wherein CLA comprise one or more 9,11-10,12-and 11, the cis of 13-octadecadienoic acid and trans forms isomer; The CLA derivant is ethyl ester, the triglyceride of CLA, calcium salt, zinc salt and other possible derivant or salt.
6, according to the CLA and the derivant thereof of claim 1 or 5, the consumption that it is characterized in that conjugated linoleic acid (CLA) and derivant thereof is 0.01-20% (W/W).
7, according to the described preparation of claim 4, tool antioxidation biological active substances commonly used is vitamin E or TBHQ or tea polyphenols or selenium (Se).
8, according to the described preparation of claim 7; tool antioxidation biological active substances commonly used; except protection CLA and derivant thereof are brought into normal play the physiological function; also play a part the collaborative interior free yl of removing; increase at muscle especially; the movable back that strengthens of human body produces more freedom base situation, reaches the effect of environment in the cleaning human body.
CN 200510034419 2005-04-23 2005-04-23 Oral use of conjugated linoleic acid and its derivatives for muscle building and skin beautification Pending CN1850065A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200510034419 CN1850065A (en) 2005-04-23 2005-04-23 Oral use of conjugated linoleic acid and its derivatives for muscle building and skin beautification

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200510034419 CN1850065A (en) 2005-04-23 2005-04-23 Oral use of conjugated linoleic acid and its derivatives for muscle building and skin beautification

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CNA2007101486144A Division CN101129352A (en) 2005-04-23 2005-04-23 Use of oral calcium conjugate linoleate for skin beauty

Publications (1)

Publication Number Publication Date
CN1850065A true CN1850065A (en) 2006-10-25

Family

ID=37131577

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200510034419 Pending CN1850065A (en) 2005-04-23 2005-04-23 Oral use of conjugated linoleic acid and its derivatives for muscle building and skin beautification

Country Status (1)

Country Link
CN (1) CN1850065A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101945653A (en) * 2008-01-02 2011-01-12 海洋生物有限公司 Compositions and methods for treating neurodegenerative diseases
CN103385516A (en) * 2013-07-29 2013-11-13 安徽燕之坊食品有限公司 Liquid supplement
CN112546195A (en) * 2020-12-16 2021-03-26 刘袭文 Safflower polypeptide light tablet
CN112674208A (en) * 2020-12-30 2021-04-20 华南农业大学 Application of trans-10 cis-12 conjugated linoleic acid in enhancing skeletal muscle exercise endurance
CN114097938A (en) * 2021-10-27 2022-03-01 浙江大学 Feed for promoting muscle injury repair of mice and application
WO2022087684A1 (en) * 2020-10-30 2022-05-05 Animal Control Technologies (Australia) Pty Ltd Hygroscopic salt microencapsulation, and uses thereof

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101945653A (en) * 2008-01-02 2011-01-12 海洋生物有限公司 Compositions and methods for treating neurodegenerative diseases
CN103385516A (en) * 2013-07-29 2013-11-13 安徽燕之坊食品有限公司 Liquid supplement
WO2022087684A1 (en) * 2020-10-30 2022-05-05 Animal Control Technologies (Australia) Pty Ltd Hygroscopic salt microencapsulation, and uses thereof
EP4236692A4 (en) * 2020-10-30 2024-10-16 Animal Control Technologies (Australia) Pty Ltd Hygroscopic salt microencapsulation, and uses thereof
CN112546195A (en) * 2020-12-16 2021-03-26 刘袭文 Safflower polypeptide light tablet
CN112674208A (en) * 2020-12-30 2021-04-20 华南农业大学 Application of trans-10 cis-12 conjugated linoleic acid in enhancing skeletal muscle exercise endurance
CN114097938A (en) * 2021-10-27 2022-03-01 浙江大学 Feed for promoting muscle injury repair of mice and application

Similar Documents

Publication Publication Date Title
CN108618129A (en) Sarcopenia tailored version clinical nutrition formula and preparation method thereof
JP6205616B2 (en) Beautiful skin promoter and its use
JP5102434B2 (en) Orally administrable composition for improving skin quality
JPWO2006093267A1 (en) Fermentation composition having immunomodulatory action
JP5685752B2 (en) Blood flow promoting agent
CN103493983B (en) Feed additive for improving fur quality of fur-bearing animal and manufacturing method thereof
JP2008074816A (en) In vivo antioxidant
KR102525595B1 (en) Health food composition containing fish collagen
CN104543379A (en) Plant extract contained pet feed with health care function and preparation method of pet feed
JP2025003735A (en) Oral Compositions
JP5597828B2 (en) Hair restorer
CN1850065A (en) Oral use of conjugated linoleic acid and its derivatives for muscle building and skin beautification
JP2012067082A (en) Oral composition
CN1271187C (en) Perilla oil and its preparation process and use
TW202421177A (en) Composition for ameliorating fatigue, sleep disturbance or eye fatigue and menopausal symptoms
KR101757841B1 (en) Composition for inhibiting obesity comprising complex salt of baicalin and zinc
KR20180133271A (en) Preparations using herbal medicine extracts and powders and their manufacturing methods
CN107006699A (en) A kind of meat sheep feed containing Chinese herbal medicine
JP6024942B2 (en) Testosterone secretion promoter, anti-fatigue agent, and production method and use thereof
CN101129352A (en) Use of oral calcium conjugate linoleate for skin beauty
EP4044824A1 (en) Nutritional supplement
KR20140070687A (en) Composition for obesity treatment and improvement which contains extract of tribulus terrestris
CN108271942A (en) A kind of pigeon feed and preparation method thereof
JP7131785B1 (en) Skin moisturizing agent and skin barrier function improving agent
JP7421184B2 (en) Agents for increasing and/or maintaining skin moisture content and skin oil content

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Open date: 20061025